Note: Ingredients listed on restricted chemical lists
EC/CAS
205-781-3
Name of the chemical
2-Methyl-1-phenyl-2-propyl acetate; Dimethylbenzyl Carbinyl Acetate (40)
Concentration
<= 100 %
General Information
Version
8.1
Revision date
2025-10-20
Product name
alpha,alpha-Dimethylphenethyl acetate
CAS No.
151-05-3
REACH No
A
Emergency telephone
+56 2 2581 4934
Icons in SDS
Company Information
company name
Merck S.A
e-mail address of the competent person responsible for the Safety Data Sheet
atencionclientes@merckgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H412
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Skin irritation, (Category 2) H315: Causes skin irritation. Long-term (chronic) aquatic H412: Harmful to aquatic life with long hazard, (Category 3) lasting effects.
Signal word
Warning Warning
Hazard statements
H315 Causes skin irritation. H412 Harmful to aquatic life with long lasting effects. H412 Harmful to aquatic life with long lasting effects.
Precautionary statements
P264 Wash skin thoroughly after handling. P273 Avoid release to the environment. P280 Wear protective gloves. P302 + P352 IF ON SKIN: Wash with plenty of water. P332 + P313 If skin irritation occurs: Get medical advice/ attention. P362 + P364 Take off contaminated clothing and wash it before reuse. none
Supplemental label elements
none Reduced Labelling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
